Organovo Holdings Inc. (NASDAQ: ONVO) Stock Information | RedChip

Organovo Holdings Inc. (NASDAQ: ONVO) Listen to this Section


$0.57
+0.0120 ( +2.15% ) 44.9K

Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

Market Data


Open


$0.57

Previous close


$0.56

Volume


44.9K

Market cap


$8.69M

Day range


$0.55 - $0.60

52 week range


$0.50 - $2.05

Insider Ownership Transactions

Total Amount Purchased: -39,214.00 | $ -22,351.98

Date Type Amount Purchased Purchaser
2023-11-17 Sale -19607.00 Gobel David
2023-11-17 Sale -19607.00 Joshi Vaidehi

SEC Fillings


Form Type Description Pages Date
10-k Annual reports 89 May 31, 2024
8-k 8K-related 17 May 13, 2024
8-k 8K-related 37 May 01, 2024
8-k 8K-related 11 Apr 23, 2024
10-q Quarterly Reports 65 Feb 08, 2024
8-k 8K-related 26 Feb 07, 2024
8-k 8K-related 12 Dec 28, 2023
4 Insider transactions 1 Nov 17, 2023
4 Insider transactions 1 Nov 17, 2023
4 Insider transactions 1 Nov 17, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.